This site is intended for healthcare professionals only

More research needed into treatment of Crohn’s disease

Written by: | Published:

NICE have recommended more research in Crohn's NICE have recommended more research in Crohn's

New tests to help guide treatment for people with Crohn’s disease require further research before they can be recommended for routine use in the NHS, according to NICE.

As part of new guidance released by the organisation on the digestive condition, NICE have recommended that clinicians should collect information on their use in people whose Crohn’s disease loses response to TNF-alpha inhibitors, antibodies that can be beneficial to people with the condition.

‘Tests that can accurately measure levels of TNF-alpha inhibitors and antibodies to them could enable people with Crohn’s disease to receive treatment that’s better tailored to their needs to allow treatment optimisation with fewer side effects,’ Professor Carole Longson, director of the NICE Health Technology Evaluation Centre.

According to NICE, tailoring TNF-alpha inhibitor treatment to the patient can pose problems. This is because decisions are based on clinical judgement and ‘trial and error’. This can mean that people whose disease responds well to treatment with a TNF-alpha inhibitor may continue to receive the same level of treatment, despite a decrease in dose or withdrawing it altogether may be possible without any detrimental impact on the patient’s health. Continuing treatment may lead to patients unnecessarily experiencing side-effects of the treatment.

‘The tests reviewed in this guidance show real promise,’ added Professor Longson. ‘But the committee was concerned that, because of the complexities in interpreting test results there is a risk they could be incorrectly used by clinicians without specialist knowledge of immunoassay analysis. The committee therefore concluded that in people with Crohn’s disease whose disease loses response to TNF alpha inhibitors, for the time being, these tests should be used only in those laboratories that have specialist expertise in immunoassay analysis.’

What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.

Comments

Name
 
Email
 
Comments
 

Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code
 

Newsletter

Sign up to the newsletter

About

Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.

Newsletter

Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.

Archive

Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team

Authors

Find out how to contribute to Independent Nurse here.